Maturation of mHealth
Robert Istepanian of the Institute of Global Innovation at the UK's Imperial College sees clear evidence that mHealth is valuable in treating chronic diseases. However, standards, governance and integration still need work.
Want to get more stories like this
one? Get daily news updates from Healthcare IT News.
Most Read
Research
White Papers
Patient Engagement
Patient Engagement
Financial/Revenue Cycle Management
Webinars
Artificial Intelligence
